Teleflex Incorporated

Equities

TFX

US8793691069

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:01 2024-04-26 pm EDT			5-day change	1st Jan Change
206.7 ^USD	0.00%		+0.07%	-17.10%

Apr. 15	Truist Securities Adjusts Teleflex Price Target to $240 From $265, Hold Rating Kept	MT
Apr. 02	Teleflex Incorporated Introduces the UroLift? 2 System with Advanced Tissue Control, A Revolutionary Unified Platform Designed to Treat All Prostate Types	CI

Teleflex Incorporated Provides Earnings Guidance for the Year 2024

February 22, 2024 at 06:30 am EST

Teleflex Incorporated provided earnings guidance for the year 2024. For the year, the company GAAP revenue growth guidance range of 3.60% to 4.60%, GAAP EPS from continuing operations guidance range of $5.69 to $6.09.

Latest news about Teleflex Incorporated

Truist Securities Adjusts Teleflex Price Target to $240 From $265, Hold Rating Kept	Apr. 15	MT
Teleflex Incorporated Introduces the UroLift? 2 System with Advanced Tissue Control, A Revolutionary Unified Platform Designed to Treat All Prostate Types	Apr. 02	CI
Teleflex Gets Science Based Targets Initiative Validation For Climate Targets	Mar. 28	MT
Teleflex Insider Sold Shares Worth $1,713,825, According to a Recent SEC Filing	Mar. 06	MT
Teleflex to Seek M&A	Mar. 05	CI
Transcript : Teleflex Incorporated Presents at 45th Annual Raymond James Institutional Investors Conference 2024, Mar-05-2024 01:40 PM	Mar. 05
Truist Securities Trims Price Target on Teleflex to $265 From $270, Maintains Hold Rating	Feb. 23	MT
RBC Cuts Price Target on Teleflex to $265 From $272, Keeps Outperform Rating	Feb. 23	MT
Teleflex to Seek M&A	Feb. 22	CI
Transcript : Teleflex Incorporated, Q4 2023 Earnings Call, Feb 22, 2024	Feb. 22
Teleflex's Q4 Adjusted Earnings Fall, Revenue Rises; 2024 Guidance Issued	Feb. 22	MT
Teleflex Incorporated Announces Quarterly Dividend, Payable on March 15, 2024	Feb. 22	CI
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q4 Revenue $773.9M	Feb. 22	MT
Earnings Flash (TFX) TELEFLEX INCORPORATED Posts Q4 EPS $3.38	Feb. 22	MT
Teleflex Incorporated Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	Feb. 22	CI
Teleflex Incorporated Provides Earnings Guidance for the Year 2024	Feb. 22	CI
MORNING BID AMERICAS-AI 'tipping point' sends Nvidia, Nasdaq, Nikkei north	Feb. 22	RE
Trump is back (and so is Wall Street)	Jan. 16
ANALYST RECOMMENDATIONS : AMD, Cloudflare, Intel, ITV, PayPal...	Jan. 16
RBC Boosts Price Target on Teleflex to $272 From $228 on Recent Stock Rise, Peer Multiples, 'Durable Growth Story'; Outperform Kept	Jan. 12	MT
Transcript : Teleflex Incorporated Presents at J.P. Morgan 42nd Annual Healthcare Conference 2024, Jan-09-2024 03:00 PM	Jan. 09
Teleflex Incorporated Offers Its Titan SGS Stapler with Staple Line Reinforcement	Jan. 09	CI
Truist Securities Hikes Price Target on Teleflex to $270 From $221, Maintains Hold Rating	Dec. 22	MT
Raymond James Adjusts Price Target on Teleflex to $271 From $227, Keeps Outperform Rating	Dec. 20	MT
Teleflex Incorporated Wins Peripheral Access Agreement with Premier, Inc	Dec. 05	CI

Chart Teleflex Incorporated

Duration

Period

More charts

Company Profile

Teleflex Incorporated specialises in the designing, manufacturing and selling of single-use medical devices for hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. Products are sold under the brand names Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch® and Weck®. Net sales break down by category of products as follows: - interventional cardiology, radiology and urology products (26.5%); - vascular access solutions (25.9%); - surgical devices (12.5%); - anesthesia products (11.9%); - other (23.2%). Net sales are distributed geographically as follows: the United States (61.8%), Europe (25.5%), Asia-Pacific (9.1%) and other (3.6%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-02 - Q1 2024 Earnings Release

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Teleflex Incorporated

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

206.7 USD

Average target price

262.4 USD

Spread / Average Target

+26.95%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
TELEFLEX INCORPORATED	-17.10%	9.74B
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution